- Home
- TLSI vs WRN Comparison
TLSI vs WRN Comparison
Compare TLSI & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- WRN
- Stock Information
- Founded
- TLSI 2010
- WRN 2006
- Country
- TLSI United States
- WRN Canada
- Employees
- TLSI N/A
- WRN N/A
- Industry
- TLSI Medical Specialities
- WRN Metal Mining
- Sector
- TLSI Health Care
- WRN Basic Materials
- Exchange
- TLSI Nasdaq
- WRN Nasdaq
- Market Cap
- TLSI 204.0M
- WRN 228.0M
- IPO Year
- TLSI N/A
- WRN N/A
- Fundamental
- Price
- TLSI $5.43
- WRN $1.23
- Analyst Decision
- TLSI Strong Buy
- WRN Strong Buy
- Analyst Count
- TLSI 5
- WRN 1
- Target Price
- TLSI $10.90
- WRN $4.00
- AVG Volume (30 Days)
- TLSI 146.8K
- WRN 355.6K
- Earning Date
- TLSI 08-13-2025
- WRN 08-08-2025
- Dividend Yield
- TLSI N/A
- WRN N/A
- EPS Growth
- TLSI N/A
- WRN N/A
- EPS
- TLSI N/A
- WRN N/A
- Revenue
- TLSI $32,141,000.00
- WRN N/A
- Revenue This Year
- TLSI $55.52
- WRN N/A
- Revenue Next Year
- TLSI $54.76
- WRN N/A
- P/E Ratio
- TLSI N/A
- WRN N/A
- Revenue Growth
- TLSI 46.20
- WRN N/A
- 52 Week Low
- TLSI $3.50
- WRN $0.90
- 52 Week High
- TLSI $6.04
- WRN $1.42
- Technical
- Relative Strength Index (RSI)
- TLSI 50.01
- WRN 49.42
- Support Level
- TLSI $5.18
- WRN $1.18
- Resistance Level
- TLSI $5.65
- WRN $1.26
- Average True Range (ATR)
- TLSI 0.35
- WRN 0.06
- MACD
- TLSI -0.02
- WRN -0.01
- Stochastic Oscillator
- TLSI 49.23
- WRN 20.42
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).